Northern Institute for Cancer Research

Target Discovery and Validation

Target Discovery and Validation

About

We're working alongside colleagues in the Cancer Drug Discovery group. Together, we're identifying a wider range of druggable targets in many types of adult cancer.

Research Leaders

Luke Gaughan
Stuart McCracken
Kenneth Rankin
Helen Reeves
Craig Robson

About

Current cancer therapeutics are directed against a limited number of cellular targets. Their effectiveness is hampered by the emergence of resistance to the treatment.

We invest in supporting validation studies. We use well-annotated cancer biobanks to confirm the importance of these targets in cancer patients.

Staff